持续气道正压与下颌前移矫治器的CHOICE多中心开放标签随机临床试验
这项多中心、双随机、三阶段试验纳入初治轻至重度阻塞性睡眠呼吸暂停患者,比较持续气道正压(CPAP)与下颌前移矫治器(MAS)的客观依从性。交叉阶段MAS依从性高于CPAP(6.0 vs 5.3 h·night-1,差值0.7,95%CI 0.3-1.2,p<0.001),CPAP疗效优于MAS(差值10.4 events·h-1,95%CI 7.8-13.0,p<0.001),但两者对患者中心结局的临床有效性相当。
要点
- MAS客观依从性高于CPAP,但CPAP在降低呼吸事件方面疗效更优。
- 两种治疗对患者中心结局的改善程度相当,临床有效性可比。
- 观察期55%患者选择交替使用两种疗法,提示联合管理可优化长期治疗。
核心结论
- CPAP疗效更高而MAS依从性更高,两者对患者中心结局的临床有效性相当。
- 同时提供CPAP和MAS可改善OSA的长期管理。
研究设计与样本
- 多中心、双随机、三阶段(滴定/交叉/观察)试验,在加拿大三所大学开展。
- 纳入初治轻至重度OSA患者,第一随机化81例,79例进入适应/滴定阶段(平均年龄52.3±10.8岁,58例男性),73例进入交叉阶段并纳入意向性治疗分析,64例完成观察阶段。
- 交叉阶段和观察阶段时长分别为2.5个月和6个月。
主要发现
- 1个月平均客观依从性:MAS高于CPAP,6.0 vs 5.3 h·night-1(差值0.7,95%CI 0.3-1.2,p<0.001)。
- CPAP与MAS疗效平均差值:10.4(95%CI 7.8-13.0)events·h-1,p<0.001。
- 观察阶段55%(35/64)的参与者选择交替使用两种疗法。
- 所有治疗均使患者中心结局获得实质性改善。
临床怎么用
- 对于轻至重度OSA初治患者,可考虑将MAS作为CPAP的替代或交替方案以提高长期依从性。
- 临床决策可结合患者对依从性与疗效的偏好,提供两种疗法供交替使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Adherence to continuous positive airway pressure (CPAP) for obstructive sleep apnoea (OSA) continues to be low with high termination rates. Alternative therapies to CPAP are needed. Our objective was to compare objective adherence to CPAP and mandibular advancement splints (MAS) and to evaluate their effectiveness, and additionally to identify treatment usage patterns and the clinical effectiveness of having both therapies. METHODS: This multicentre, double-randomised, three-phase trial (titration/crossover/observation) was conducted at three Canadian universities. Eligible participants were treatment-naïve with mild-to-severe OSA. The primary outcome was objectively measured adherence (hours per night) during the crossover phase. Secondary outcomes included efficacy during the crossover phase; adherence during the observational phase; and patient-centred outcomes, blood pressure and side-effects during the crossover and observational phases. Duration of the crossover and observational phase was 2.5 and 6 months, respectively. RESULTS: 81 participants were enrolled in the first randomisation. 79 entered the adaptation/titration phase (mean±sd age 52.3±10.8 years; 58 males), 73 entered the crossover phase (included in the intention-to-treat analysis) and 64 completed the observational phase. Mean objective adherence over 1 month: MAS showed higher adherence than CPAP, 6.0 versus 5.3 h·night-1 (difference 0.7 (95% CI 0.3-1.2) h·night-1; p<0.001). Mean CPAP-MAS difference in efficacy: 10.4 (95% CI 7.8-13.0) events·h-1; p<0.001. During the observational phase 55% (35 out of 64) of participants chose to alternate therapies. All treatments led to substantial improvement in patient-centred outcomes. CONCLUSIONS: Despite the higher efficacy of CPAP and higher adherence to MAS, both demonstrate comparable clinical effectiveness on patient-centred outcomes. Having both CPAP and MAS can improve long-term management of OSA.
引用
- Hamoda MM, Huynh N, Ayas NT, et al. Continuous positive airway pressure and mandibular advancement splints: the CHOICE multicentre, open-label randomised clinical trial. Eur Respir J. 2025. PMID: 39638418. doi:10.1183/13993003.01100-2024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。